Free Trial!
Today’s Best Stocks To Trade! Click Here
Greenlight Capital Re Ltd. (NASDAQ: GLRE | news | PowerRating | PR Charts ) through its subsidiary, Greenlight Reinsurance, Ltd., provides specialty property and casualty reinsurance services worldwide. It offers a range of property and casualty reinsurance products, including casualty and liability risks, medical malpractice, natural peril/property/damage, professional liability, surety and fidelity, and workers' compensation. The company underwrites reinsurance in two categories, frequency business and severity business. The frequency business principally consists of contracts containing a potentially large number of smaller losses emanating from multiple events. The severity business consists of contracts with the potential for significant losses emanating from one event. Greenlight Capital was founded in 2004 and is based in Grand Cayman, Cayman Islands. With 29.85 million shares outstanding and 1.23 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of GLRE. According to quarterly data provided by the SEC, there were still 40,643 shares of GLRE that were failing-to-deliver as of September 28, 2007.
HydroGen Corp. (NASDAQ: HYDG | news | PowerRating | PR Charts ) a development stage company, through its wholly owned subsidiary, HydroGen, LLC, engages in the design, manufacture, marketing, and distribution of power generation systems for commercial and large scale stationary applications in the United States. The company manufactures multi-megawatt fuel cell systems utilizing proprietary 400-kilowatt air-cooled phosphoric acid fuel cell technology. HydroGen Corporation is headquartered in Cleveland, Ohio. With 12.77 million shares outstanding and 239,000 shares declared short as of March 2008, there is no longer a failure to deliver in shares of HYDG. According to quarterly data provided by the SEC, there were still 59,145 shares of HYDG that were failing-to-deliver as of September 20, 2007.
Imperial Sugar Company (NASDAQ: IPSU | news | PowerRating | PR Charts ) together with its subsidiaries, engages in the processing and marketing of refined sugar in the United States. It refines, packages, and distributes granulated white, powdered, liquid, and brown sugars. The company also produces specialty sugar products, including Savannah Gold brown sugar primarily for industrial customers; co-crystallized products; edible molasses; syrups; and specialty sugars used in confections, fondants, and icings. Imperial Sugar markets its products under various brand names, such as Dixie Crystals, Holly, and Imperial, as well as under private labels. It sells its products to retailers, foodservice distributors, and industrial food manufacturers directly through its sales force, as well as through wholesalers and distributors. The company was founded in 1843 and is headquartered in Sugar Land, Texas with an additional office in Port Wentworth, Georgia. With 11.82 million shares outstanding and 3.22 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of IPSU. According to quarterly data provided by the SEC, there were still 12,826 shares of IPSU that were failing-to-deliver as of September 28, 2007.
Molecular Insight Pharmaceuticals Inc. (NASDAQ: MIPI | news | PowerRating | PR Charts ) a development stage biopharmaceutical company, engages in the research, development, and commercialization of molecular imaging pharmaceuticals and radiotherapeutics primarily in the areas of oncology and cardiology in the United States. The company's products under development include Azedra, a Phase I clinical-stage radiotherapeutic product candidate for the treatment of adult patients with various forms of neuroendocrine cancer, such as carcinoid or pheochromocytoma; and Onalta, a clinical-stage radiotherapeutic product candidate for the treatment of somatostatin positive pancreatic neuroendocrine and carcinoid tumors. It is also developing Zemiva, a molecular imaging pharmaceutical product candidate for the diagnosis of cardiac ischemia or insufficient blood flow to the heart in the emergency department setting, as well as for the diagnosis of coronary disease in the non-acute setting. In addition, its products under development include Solazed, a radiotherapeutic for the treatment of malignant metastatic melanoma; MIP-220, a molecular imaging pharmaceutical product for detection of prostate-specific membrane antigen, which enables the detection and monitoring of prostate cancer; MIP-190 to assess the progression of heart failure through the monitoring of angiotensin converting enzyme in human hearts; and MIP-170D, a molecular imaging pharmaceutical compound to aid in the objective diagnosis of Parkinson's disease and attention deficit hyperactivity disorder. The company was founded in 1997 as Imaging Biopharmaceuticals, Inc. and changed its name to Biostream, Inc. in 1998. Further, it changed its name to Molecular Insight Pharmaceuticals, Inc. in 2003. The company is based in Cambridge, Massachusetts. With 24.86 million shares outstanding and 461,000 shares declared short as of March 2008, there is no longer a failure to deliver in shares of MIPI. According to quarterly data provided by the SEC, there were still 45,194 shares of MIPI that were failing-to-deliver as of September 21, 2007.
Rackable Systems Inc. (NASDAQ: RACK | news | PowerRating | PR Charts ) engages in the design, manufacture, and implementation of compute servers and storage systems in the United States. It offers Foundation Series compute servers for single or dual processor motherboards that support AMD and Intel 32-and 32/64-bit processors, such as the AMD Opteron, Intel Pentium 4, and Intel Xeon. The company also offers Foundation Series compute servers for two processor motherboards supporting the 64-bit Intel Itanium 2 processor, and for four processor motherboards supporting the 32/64-bit AMD Opteron 800 Series processors. In addition, it offers Scale Out Series Compute Server, RapidScale Storage Appliance, and Foundation Series Storage Server. Further, the company also offers service and support packages associated with hardware break-fix support and onsite hardware services. Its professional services include onsite cabling assistance and installation of third-party software, such as grid, clustering, and utility computing applications. Rackable Systems sells its products to customers in Internet businesses; and companies in vertical markets, such as semiconductor design, enterprise software, federal government, entertainment, financial services, oil and gas exploration, biotechnology, and pharmaceuticals. The company was founded in 1999 and is headquartered in Fremont, California. With 29.64 million shares outstanding and 3.32 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of RACK. According to quarterly data provided by the SEC, there were still 91,037 shares of RACK that were failing-to-deliver as of September 28, 2007.
ICP Solar Technologies Inc. (OTCBB: ICPR | news | PowerRating | PR Charts ) is a developer, manufacturer and marketer of solar cells and solar cell based products and building materials. Through the application of next-generation technologies and use of proprietary intellectual design the Company aims to be the industry's innovation leader. For the past 19 years, ICP Solar has led the consumer market through innovation and has now begun to apply that same philosophy to the OEM, rooftop and power generation segment of the solar industry .ICP Solar's management has over 50 years of experience in the renewable energy sector. The company's headquarters are located in Montreal, Canada, with additional locations in the USA, Spain, Ireland and France. With 32.65 million shares outstanding and 208,900 shares declared short as of March 2008, there is no longer a failure to deliver in shares of ICPR. According to quarterly data provided by the SEC, there were still 21,310 shares of ICPR that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,850,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
